tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ONVO Stock Latest News

Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
Press ReleasesOrganovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
1d ago
ONVO
Organovo announces Phase 2 results for FXR314
PremiumThe Fly
Organovo announces Phase 2 results for FXR314
1d ago
ONVO
Organovo files to sell common stock, warrants, no amount given
PremiumThe Fly
Organovo files to sell common stock, warrants, no amount given
4d ago
ONVO
Organovo Holdings Unveils Corporate Presentation Online
PremiumCompany Announcements
Organovo Holdings Unveils Corporate Presentation Online
2M ago
8K
ONVO
Organovo files $150M mixed securities shelf
PremiumThe Fly
Organovo files $150M mixed securities shelf
3M ago
ONVO
Organovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress
PremiumPress ReleasesOrganovo Presents FXR314 3D Human Tissue Model Findings That Show Improved Epithelial Barrier Function and Fibrosis Reduction at Crohn’s and Colitis Congress
3M ago
ONVO
Organovo presents FXR314 3D human tissue model findings
PremiumThe Fly
Organovo presents FXR314 3D human tissue model findings
3M ago
ONVO
Organovo to present FXR314 model findings at Crohn’s, Colitis Congress
PremiumThe Fly
Organovo to present FXR314 model findings at Crohn’s, Colitis Congress
3M ago
ONVO
Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress
PremiumPress Releases
Organovo To Present FXR314 IBD 3D Model Findings at Upcoming Crohn’s and Colitis Congress
3M ago
ONVO
Organovo provides timing for release of FXR314 Phase 2 NASH results
PremiumThe Fly
Organovo provides timing for release of FXR314 Phase 2 NASH results
4M ago
ONVO
Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results
PremiumPress Releases
Organovo Provides Timing for Release of FXR314 Phase 2 NASH Results
4M ago
ONVO
CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan
PremiumPress Releases
CORRECTION – Organovo Highlights FXR314 Combination Therapy Potential and Plan
5M ago
ONVO
Organovo highlights FXR314 combination therapy potential, plan
PremiumThe FlyOrganovo highlights FXR314 combination therapy potential, plan
5M ago
ONVO
Organovo Highlights FXR314 Combination Therapy Potential and Plan
PremiumPress Releases
Organovo Highlights FXR314 Combination Therapy Potential and Plan
5M ago
ONVO
Organovo to Participate in the H.C. Wainwright Global Investment Conference
PremiumPress Releases
Organovo to Participate in the H.C. Wainwright Global Investment Conference
7M ago
ONVO
Organovo announces details on its clinical program for FXR314
PremiumThe Fly
Organovo announces details on its clinical program for FXR314
8M ago
ONVO
Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
PremiumPress Releases
Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
8M ago
ONVO
Organovo announces clinical program for FXR 314
PremiumThe Fly
Organovo announces clinical program for FXR 314
1y ago
ONVO
Organovo Announces FXR Program
PremiumPress Releases
Organovo Announces FXR Program
1y ago
ONVO
Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates
PremiumPress ReleasesOrganovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn’s Disease Drug Candidates
1y ago
ONVO
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
PremiumPress Releases
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
2y ago
ONVO
Organovo Announces Postponement of Annual Meeting of Stockholders
PremiumPress Releases
Organovo Announces Postponement of Annual Meeting of Stockholders
2y ago
ONVO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >